Young Joseph R, SVP of Finance and Chief Accounting Officer at Vera Therapeutics ($VERA), made two open market sales of company shares in the last year, totaling about $567 thousand. His most recent sale was on February 23, 2026. These transactions rank 6,178th among 11,678 insiders in our database, where the average is $8.6 million across roughly 6.4 sales. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | M | Class A Common Stock | 10000 | $3.94 | 75,754.0000 | 63,928,066 | 15.21% | 0.02% |
| March 13, 2026 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | M | Stock Option (right to buy) | 10000 | $0.00 | 38,589.0000 | 63,928,066 | 20.58% | 0.02% |
| Feb. 23, 2026 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | S | Class A Common Stock | 3117 | $41.98 | 64,722.0000 | 63,928,066 | 4.59% | 0.00% |
| Feb. 4, 2026 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | A | Class A Common Stock | 10000 | $0.00 | 67,839.0000 | 63,928,066 | 17.29% | 0.02% |
| Feb. 4, 2026 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 63,928,066 | 9999.99% | 0.03% |
| Nov. 13, 2025 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | M | Stock Option (right to buy) | 10000 | $0.00 | 48,589.0000 | 63,928,066 | 17.07% | 0.02% |
| Nov. 11, 2025 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | S | Class A Common Stock | 15000 | $29.06 | 47,839.0000 | 63,928,066 | 23.87% | 0.02% |
| Nov. 13, 2025 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | M | Class A Common Stock | 10000 | $3.94 | 57,839.0000 | 63,928,066 | 20.90% | 0.02% |
| Feb. 18, 2025 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | A | Stock Option (right to buy) | 21500 | $0.00 | 21,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2025 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | A | Class A Common Stock | 10740 | $0.00 | 61,946.0000 | 0 | 20.97% | 0.00% |
| May 16, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | S | Class A Common Stock | 2500 | $43.03 | 51,206.0000 | 0 | 4.65% | 0.00% |
| May 15, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | M | Stock Option (right to buy) | 8221 | $0.00 | 58,589.0000 | 0 | 12.31% | 0.00% |
| May 16, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | M | Stock Option (right to buy) | 20651 | $0.00 | 69,349.0000 | 0 | 22.95% | 0.00% |
| May 15, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | S | Class A Common Stock | 8221 | $42.17 | 53,171.0000 | 0 | 13.39% | 0.00% |
| May 15, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | M | Class A Common Stock | 8221 | $3.94 | 61,392.0000 | 0 | 15.46% | 0.00% |
| May 15, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | S | Class A Common Stock | 1965 | $42.68 | 51,206.0000 | 0 | 3.70% | 0.00% |
| May 16, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | S | Class A Common Stock | 18151 | $42.22 | 51,206.0000 | 0 | 26.17% | 0.00% |
| May 16, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | M | Class A Common Stock | 18151 | $7.87 | 69,357.0000 | 0 | 35.45% | 0.00% |
| May 16, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | M | Class A Common Stock | 2500 | $7.87 | 53,706.0000 | 0 | 4.88% | 0.00% |
| April 10, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | S | Class A Common Stock | 5714 | $40.00 | 53,171.0000 | 0 | 9.70% | 0.00% |
| Jan. 16, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | A | Stock Option (right to buy) | 81250 | $0.00 | 81,250.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | A | Class A Common Stock | 21875 | $0.00 | 57,054.0000 | 0 | 62.18% | 0.00% |
| July 5, 2023 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, Finance, Chief Acct Offcr | M | Class A Common Stock | 10000 | $3.94 | 32,679.0000 | 0 | 44.09% | 0.00% |
| July 5, 2023 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, Finance, Chief Acct Offcr | M | Stock Option (right to buy) | 10000 | $0.00 | 66,810.0000 | 0 | 13.02% | 0.00% |
| Feb. 6, 2023 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, Finance, Chief Acct Offcr | P | Class A Common Stock | 5714 | $7.00 | 22,679.0000 | 0 | 33.68% | 0.00% |
| Feb. 15, 2023 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, Finance, Chief Acct Offcr | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2022 | Vera Therapeutics, Inc. | $VERA | Young Joseph R | SVP, Finance, Chief Acct Offcr | P | Class A Common Stock | 5714 | $7.00 | 22,679.0000 | 0 | 33.68% | 0.00% |